Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Incorporation of additional QC during subject sample analysis. [Bioanalytics]

posted by dshah – India, 2024-03-12 18:56 (437 d 02:11 ago) – Posting: # 23906
Views: 2,865

Dear Shreyas Goswami

Even ICHM10 follows the same which is adopted by FDA and EMA.
[image]

Regards,
Divyen Shah

Complete thread:

Incorporation of additional QC during subject sample analysis. shreyas goswami 2024-03-12 09:22
- Incorporation of additional QC during subject sample analysis.dshah 2024-03-12 17:56
  - Incorporation of additional QC during subject sample analysis. shreyas goswami 2024-03-13 09:30
    - Incorporation of additional QC during subject sample analysis. ElMaestro 2024-03-14 16:26

Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
53 visitors (0 registered, 53 guests [including 26 identified bots]).
Forum time: 22:08 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body. Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz